1 / 8

Refractive Outcomes with Advanced Wavefront-Guided LASIK

Refractive Outcomes with Advanced Wavefront-Guided LASIK. William Trattler, MD Charles Reilly, MD   Consultant to the USAF SG for Refractive Surgery  Lackland AFB TX Stephen Coleman, MD   Coleman Vision  Albuquerque, NM David Schneider, MD   Mid West Eye Center  Cincinnati, OH

alder
Download Presentation

Refractive Outcomes with Advanced Wavefront-Guided LASIK

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Refractive Outcomes with Advanced Wavefront-Guided LASIK William Trattler, MD Charles Reilly, MD   Consultant to the USAF SG for Refractive Surgery  Lackland AFB TX Stephen Coleman, MD   Coleman Vision  Albuquerque, NM David Schneider, MD   Mid West Eye Center  Cincinnati, OH Eric Donnenfeld, MD   TLC , OCLI  Darden City, NY Robert Maloney, MD   Maloney Vision Los Angeles CA Larry Katzen, MD    Miami, FL

  2. Financial Disclosure • William Trattler, MD is a consultant, has received research support, and is on the speaker’s bureau for Abbott Medical Optics (AMO) • Charles Reilly, MD has no relevant disclosures • Steven Coleman is a consultant for AMO • David Schneider, MD has received funding from AMO for this study • Eric Donnenfeld, MD is a consultant for AMO, Alcon, and Bausch and Lomb • Robert Maloney, MD is a consultant for AMO & Calhoun Vision; Shareholder for Calhoun Vision • Larry Katzen, MD has received funding from AMO for this study

  3. Purpose and Methods • Purpose: • To evaluate the efficacy, safety, and predictability of an enhanced laser vision correction surgery (wavefront-guided, iris registration, and femtosecond ablation) on patients undergoing LASIK surgery. • Open-label, multicenter, prospective, non-comparative evaluation of up to 20 patients/center (40 eyes/center) scheduled to undergo primary LASIK with the Advanced CustomVue iLASIK (Advanced Medical Optics). • Follow-up was at 1 and 3 months. • Myopia must be within -0.5 to -6.0 D, cylinder up to -3 D, and MRSE of -6D. • Pre- and post-op refraction, wavescan, UCVA, BCVA, and pupilometry will be evaluated. • All re-treatment information will be recorded and compared against historical rates. • Interim analysis of 131 patients

  4. Preoperative & Intraoperative Parameters • Mean preoperative cylinder: • 0.565 D (range: 0 to 2.5D) • Mean preoperative spherical equivalence: • -2.80 D (range: -0.85 to -5.60) • Iris capture success rate • 92.5%

  5. UCVA % of Eyes

  6. Low Contrast Visual Acuity Post-Op % of Patients

  7. Patient Were Satisfied with Their Vision Without Lenses/Glasses % of Patients Four point scale: 4= Very Satisfied and 1=Very Dissatisfied.

  8. Conclusions • In this interim analysis, the CustomVue iLASIK platform provided optimal outcomes. • 65.9% of eyes had better than 20/20 UCVA at 3 months • 96.7% of eyes had 20/20 UCVA at 3 months • 100% achieved 20/25 UCVA or better at 3 months • No patients have required enhancements to date. • Patients were very satisfied with their visual outcomes. • Improved low contrast visual acuity • Patients were able to return to normal activities immediately. • 100% of patients were satisfied with their vision

More Related